Magnetic Resonance Spectroscopy, Positron Emission Tomography and Radiogenomics-Relevance to Glioma

Overview

Journal Front Neurol

Specialty Neurology

Date 2018 Feb 21

PMID 29459844

Citations 20

Authors

Gloria C Chiang

Ilhami Kovanlikaya

Changho Choi

Rohan Ramakrishna

Rajiv Magge

Dikoma C Shungu

Affiliations

Soon will be listed here.

Abstract

Advances in metabolic imaging techniques have allowed for more precise characterization of gliomas, particularly as it relates to tumor recurrence or pseudoprogression. Furthermore, the emerging field of radiogenomics where radiographic features are systemically correlated with molecular markers has the potential to achieve the holy grail of neuro-oncologic neuro-radiology, namely molecular diagnosis without requiring tissue specimens. In this section, we will review the utility of metabolic imaging and discuss the current state of the art related to the radiogenomics of glioblastoma.

Citing Articles

Advances in Glioblastoma Diagnosis: Integrating Genetics, Noninvasive Sampling, and Advanced Imaging.

Gough R, Treffy R, Krucoff M, Desai R Cancers (Basel). 2025; 17(1.

PMID: 39796751 PMC: 11720166. DOI: 10.3390/cancers17010124.

Multiparametric Analysis Combining DSC-MR Perfusion and [18F]FET-PET is Superior to a Single Parameter Approach for Differentiation of Progressive Glioma from Radiation Necrosis.

Panholzer J, Malsiner-Walli G, Grun B, Kalev O, Sonnberger M, Pichler R Clin Neuroradiol. 2023; 34(2):351-360.

PMID: 38157019 DOI: 10.1007/s00062-023-01372-1.

Astrocytoma Mimicking Herpetic Meningoencephalitis: The Role of Non-Invasive Multimodal Monitoring in Neurointensivism.

Flato U, Pereira B, Costa F, Vilela M, Frigieri G, Cavalcante N Neurol Int. 2023; 15(4):1403-1410.

PMID: 38132969 PMC: 10745918. DOI: 10.3390/neurolint15040090.

Research Progress of CXCR4-Targeting Radioligands for Oncologic Imaging.

Wang Y, Gao F Korean J Radiol. 2023; 24(9):871-889.

PMID: 37634642 PMC: 10462898. DOI: 10.3348/kjr.2023.0091.

Towards differentiation of brain tumor from radiation necrosis using multi-parametric MRI: Preliminary results at 4.7 T using rodent models.

Devan S, Jiang X, Kang H, Luo G, Xie J, Zu Z Magn Reson Imaging. 2022; 94:144-150.

PMID: 36209946 PMC: 10167709. DOI: 10.1016/j.mri.2022.10.002.

References

Pirotte B, Goldman S, Massager N, David P, Wikler D, Vandesteene A . Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas. J Nucl Med. 2004; 45(8):1293-8. View

Warburg O . On the origin of cancer cells. Science. 1956; 123(3191):309-14. DOI: 10.1126/science.123.3191.309. View

Zinn P, Mahajan B, Majadan B, Sathyan P, Singh S, Majumder S . Radiogenomic mapping of edema/cellular invasion MRI-phenotypes in glioblastoma multiforme. PLoS One. 2011; 6(10):e25451. PMC: 3187774. DOI: 10.1371/journal.pone.0025451. View

Diehn M, Nardini C, Wang D, McGovern S, Jayaraman M, Liang Y . Identification of noninvasive imaging surrogates for brain tumor gene-expression modules. Proc Natl Acad Sci U S A. 2008; 105(13):5213-8. PMC: 2278224. DOI: 10.1073/pnas.0801279105. View

Artzi M, Liberman G, Vaisman N, Bokstein F, Vitinshtein F, Aizenstein O . Changes in cerebral metabolism during ketogenic diet in patients with primary brain tumors: H-MRS study. J Neurooncol. 2017; 132(2):267-275. DOI: 10.1007/s11060-016-2364-x. View

Gerstner E, Zhang Z, Fink J, Muzi M, Hanna L, Greco E . ACRIN 6684: Assessment of Tumor Hypoxia in Newly Diagnosed Glioblastoma Using 18F-FMISO PET and MRI. Clin Cancer Res. 2016; 22(20):5079-5086. PMC: 5065740. DOI: 10.1158/1078-0432.CCR-15-2529. View

Lundemann M, Cardoso Costa J, Law I, Engelholm S, Muhic A, Poulsen H . Patterns of failure for patients with glioblastoma following O-(2-[F]fluoroethyl)-L-tyrosine PET- and MRI-guided radiotherapy. Radiother Oncol. 2017; 122(3):380-386. DOI: 10.1016/j.radonc.2017.01.002. View

Chaumeil M, Ozawa T, Park I, Scott K, James C, Nelson S . Hyperpolarized 13C MR spectroscopic imaging can be used to monitor Everolimus treatment in vivo in an orthotopic rodent model of glioblastoma. Neuroimage. 2011; 59(1):193-201. PMC: 3196046. DOI: 10.1016/j.neuroimage.2011.07.034. View

Yip S, Aerts H . Applications and limitations of radiomics. Phys Med Biol. 2016; 61(13):R150-66. PMC: 4927328. DOI: 10.1088/0031-9155/61/13/R150. View

10.

Harat M, Malkowski B, Makarewicz R . Pre-irradiation tumour volumes defined by MRI and dual time-point FET-PET for the prediction of glioblastoma multiforme recurrence: A prospective study. Radiother Oncol. 2016; 120(2):241-7. DOI: 10.1016/j.radonc.2016.06.004. View

11.

Holzer T, Herholz K, Jeske J, Heiss W . FDG-PET as a prognostic indicator in radiochemotherapy of glioblastoma. J Comput Assist Tomogr. 1993; 17(5):681-7. DOI: 10.1097/00004728-199309000-00002. View

12.

Ellingson B . Radiogenomics and imaging phenotypes in glioblastoma: novel observations and correlation with molecular characteristics. Curr Neurol Neurosci Rep. 2014; 15(1):506. DOI: 10.1007/s11910-014-0506-0. View

13.

Deng S, Zhang B, Wu Y, Zhang W, Chen Y . Detection of glioma recurrence by ¹¹C-methionine positron emission tomography and dynamic susceptibility contrast-enhanced magnetic resonance imaging: a meta-analysis. Nucl Med Commun. 2013; 34(8):758-66. DOI: 10.1097/MNM.0b013e328361f598. View

14.

Takano K, Kinoshita M, Arita H, Okita Y, Chiba Y, Kagawa N . Diagnostic and Prognostic Value of 11C-Methionine PET for Nonenhancing Gliomas. AJNR Am J Neuroradiol. 2015; 37(1):44-50. PMC: 7960211. DOI: 10.3174/ajnr.A4460. View

15.

Kickingereder P, Bonekamp D, Nowosielski M, Kratz A, Sill M, Burth S . Radiogenomics of Glioblastoma: Machine Learning-based Classification of Molecular Characteristics by Using Multiparametric and Multiregional MR Imaging Features. Radiology. 2016; 281(3):907-918. DOI: 10.1148/radiol.2016161382. View

16.

Ellingson B, Lai A, Harris R, Selfridge J, Yong W, Das K . Probabilistic radiographic atlas of glioblastoma phenotypes. AJNR Am J Neuroradiol. 2012; 34(3):533-40. PMC: 7964888. DOI: 10.3174/ajnr.A3253. View

17.

Li D, Xu Y, Wang Q, Wu H, Li H . ¹¹C-methionine and ¹⁸F-fluorodeoxyglucose positron emission tomography/CT in the evaluation of patients with suspected primary and residual/recurrent gliomas. Chin Med J (Engl). 2012; 125(1):91-6. View

18.

Colen R, Wang J, Singh S, Gutman D, Zinn P . Glioblastoma: imaging genomic mapping reveals sex-specific oncogenic associations of cell death. Radiology. 2014; 275(1):215-27. DOI: 10.1148/radiol.14141800. View

19.

Wang Q, Zhang H, Zhang J, Wu C, Zhu W, Li F . The diagnostic performance of magnetic resonance spectroscopy in differentiating high-from low-grade gliomas: A systematic review and meta-analysis. Eur Radiol. 2015; 26(8):2670-84. DOI: 10.1007/s00330-015-4046-z. View

20.

Ledezma C, Chen W, Sai V, Freitas B, Cloughesy T, Czernin J . 18F-FDOPA PET/MRI fusion in patients with primary/recurrent gliomas: initial experience. Eur J Radiol. 2008; 71(2):242-8. DOI: 10.1016/j.ejrad.2008.04.018. View